Crossref
Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli
Synthetic Biology and Engineering · 2023
DOI: 10.35534/sbe.2023.10007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthetic Biology and Engineering, 2023. Verfasst von Yujun Zhang und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhang, Y., Chen, L., Thomas, A., & Zeng, A. (2023). Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli. Synthetic Biology and Engineering. https://doi.org/10.35534/sbe.2023.10007
Vancouver
Zhang Y, Chen L, Thomas A, Zeng A. Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli. Synthetic Biology and Engineering. 2023. doi:10.35534/sbe.2023.10007
BibTeX
@article{Zhang2023,
author = {Zhang, Yujun and Chen, Lin and Thomas, Antu and Zeng, An-Ping},
title = {Development of a New 1,2,4-butanetriol Biosynthesis Pathway in an Engineered Homoserine-producing Strain of Escherichia coli},
journal = {Synthetic Biology and Engineering},
year = {2023},
doi = {10.35534/sbe.2023.10007}
}
EUVIMED